2 unknown, 2 withdrawn, 1 completed. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Unknown 2, Withdrawn 2, Completed 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Immunization, Passive: new trials by email Literature Review of Immunization, Passive trials Research Report on Immunization, Passive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer Aldesleukin, Antibody Therapy, Fluorouracil - Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma | Phase 1 / Phase 2 | Completed | Barbara Ann Karmanos Cancer Institute | 2 | 2015-12-01 | 2023-05-15 |
| Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease Immunotoxin therapy, CAT-8015 Immunotoxin, Biological therapy - Leukemia, Non-Hodgkin's Lymphoma | Phase 1 | Unknown | Cambridge Antibody Technology | 50 | 2007-08-01 | 2007-08-14 |
| Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors monoclonal antibody anti-anb3 integrin, anti-cytokine therapy, antiangiogenesis therapy - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Withdrawn | Barbara Ann Karmanos Cancer Institute | 2002-02-01 | 2014-01-16 | |
| Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer antibody therapy, biological therapy, muromonab-CD3 - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 / Phase 2 | Unknown | St. Vincent Medical Center - Los Angeles | 1991-06-01 | 2013-11-06 | |
| BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia BL22 immunotoxin, antibody therapy, biological response modifier therapy - Leukemia, Lymphoma | Phase 1 | Withdrawn | National Cancer Institute (NCI) | 2015-04-28 |
Leukemia (2) · Lymphoma, Non-Hodgkin (2) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Prolymphocytic (1) · Lymphoma (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Large-Cell, Immunoblastic (1) · Lymphoma, Mantle-Cell (1) · Pancreatic Neoplasms (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Barbara Ann Karmanos Cancer Institute (2) · Cambridge Antibody Technology (1) · National Cancer Institute (NCI) (1) · St. Vincent Medical Center - Los Angeles (1)
United States (4) · Poland (1)
Anthony Shields (1) · Charles L. Wiseman, MD, FACP (1) · Patricia LoRusso, DO (1) · Robert Kreitman, MD (1)
P30CA022453 (1)